Stephen Taras Rapundalo

Title: The Innovations of Stephen Taras Rapundalo

Introduction

Stephen Taras Rapundalo is an accomplished inventor based in Ann Arbor, MI (US). He is known for his significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit serine proteases. His work has implications for treating various disease states characterized by abnormal thrombosis.

Latest Patents

Rapundalo holds a patent for "Benzoxazinoes/benzothiazinones as serine protease inhibitors." This invention discloses benzoxazinone and benzothiazinone compounds that exhibit inhibitory effects on serine proteases such as factor Xa, thrombin, and/or factor VIIa. The patent also includes pharmaceutically acceptable salts of these compounds, compositions comprising the compounds or their salts, and methods for using them as therapeutic agents.

Career Highlights

Stephen Taras Rapundalo has made significant strides in his career, particularly through his work at Warner-Lambert Company. His innovative research has contributed to advancements in pharmaceutical sciences, particularly in the area of coagulation and thrombosis.

Collaborations

Rapundalo has collaborated with notable colleagues, including Kent A Berryman and Dennis M Downing. These collaborations have further enriched his research and development efforts in the field.

Conclusion

Stephen Taras Rapundalo's contributions to medicinal chemistry and his innovative patent on serine protease inhibitors highlight his role as a key figure in the advancement of therapeutic agents. His work continues to influence the medical field and offers promising avenues for future research.